High Resolution Computed Tomography (HRCT) Imaging Features and Disease Severity in Patients with Clinically Severe COVID-19 Pneumonia Having Diabetes Mellitus and Hypertension Using Chest CT Severity Score (CHEST CT-SS)

Ayesha Hanif; Umar Kaleem; Muhammad Ali Kaleem; Shabana Ashfaq

doi:10.51253/pafmj.v74i1.7203

Authors

Ayesha Hanif Department of Radiology, Combined Military Hospital, Okara/National University of Medical Sciences (NUMS) Pakistan
Umar Kaleem Department of Medicine, Rawalpindi Medical University, Rawalpindi Pakistan
Muhammad Ali Kaleem Department of Biomedical Engineer, National University of Sciences and Technology, Islamabad Pakistan
Shabana Ashfaq Department of Radiology, Combined Military Hospital, Abbottabad/National University of Medical Sciences (NUMS) Pakistan

DOI:

https://doi.org/10.51253/pafmj.v74i1.7203

Keywords:

Bronchiectasis, COVID-19, Chest CT severity score, Ground glass opacities, High-resolution computed tomography, Pleural effusions, Severe critical COVID-19 pneumonia

Abstract

Objective: To determine the association of diabetes and hypertension with the severity of disease by evaluation through HighResolution Computed Tomography, keeping a Chest CT severity score of 19.5 or greater as a reference for severe disease.

Study Design: Cross-sectional study.

Place and Duration of Study: Department of Diagnostic Radiology Combined Military Hospital, Okara, Pakistan from Apr
2020 to Mar 2021.

Methodology: A total of 60 patients, both male and female, aged 50 years and above, having SARS -C0V-2 infection confirmed through polymerase chain reaction presenting with the severe disease diabetes, hypertension or both as comorbid were selected. Patients' clinical information was taken from medical records from our data collection centre after informed consent from attendants.

Results: Forty-five (75%) out of 60 patients presenting clinically with severe COVID–19 pneumonia having diabetes mellitus,
hypertension, or both as co-morbids had Chest CT severity score of 19.5 or greater. 15(25%) patients had Chest CT severity
scores of less than 19.5. All the patients had bilateral multi-lobe involvement. 54(90%) patients demonstrated typical imaging features, and 14(23.3%) demonstrated atypical ones.

Conclusions: Patients aged 50 years and above having diabetes, hypertension or both as comorbid presenting clinically with severe disease developed severe critical COVID-19 pneumonia with Chest CT – severity score of 19.5 or greater having typical imaging features on High-resolution computed tomography.

Downloads

Download data is not yet available.

References

Jiang S, Shi Z, Shu Y, Song J, Gao GF, Tan W, et al. A distinct name

is needed for the new coronavirus. Lancet 2020; 395(10228): 949.

https://doi.org/10.1016/S0140-6736(20)30419-0.

Coronaviridae Study Group of the International Committee on

Taxonomy of Viruses. The species Severe acute respiratory

syndrome-related coronavirus: classifying 2019-nCoV and

naming it SARS-CoV-2. Nat Microbiol 2020; 5(4): 536-544.

https://doi.org/10.1038/s41564-020-0695-z.

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al; China Novel

Coronavirus Investigating and Research Team. A Novel

Coronavirus from Patients with Pneumonia in China, 2019. N

Engl J Med 2020; 382(8): 727-733.

https://doi.org/10.1056/NEJMoa2001017.

Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM, et al. A major

outbreak of severe acute respiratory syndrome in Hong Kong. N

Engl J Med 2003; 348(20): 1986-94.

https://doi.org/10.1056/NEJMoa030685.

Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S,

Al-Barrak A, et al. Epidemiological, demographic, and clinical

characteristics of 47 cases of Middle East respiratory syndrome

coronavirus disease from Saudi Arabia: a descriptive study.

Lancet Infect Dis 2013; 13(9): 752-761.

https://doi.org/10.1016/S1473-3099(13)70204-4.

Francone M, Iafrate F, Masci GM, Coco S, Cilia F, Manganaro L, et

al. Chest CT score in COVID-19 patients: correlation with disease

severity and short-term prognosis. Eur Radiol 2020; 30(12): 6808-

https://doi.org/10.1007/s00330-020-07033-y.

Kwee TC, Kwee RM. Chest CT in COVID-19: What the radiologist

needs to know. Radiographics 2020; 40(7): 1848-1865.

https://doi.org/10.1148/rg.2020200159.

Caruso D, Polidori T, Guido G, Nicolai M, Bracci B, Cremona A, et

al. Typical and atypical COVID-19 computed tomography

findings. World J Clin Cases 2020; 8(15): 3177-3187.

https://doi.org/10.12998/wjcc.v8.i15.3177.

Fang L, Karakiulakis G, Roth M. Are patients with hypertension

and diabetes mellitus at increased risk for COVID-19 infection?

Lancet Respir Med 2020; 8(4): e21.

https://doi.org/10.1016/S2213-2600(20)30116-8.

Zhang N, Xu X, Zhou LY, Chen G, Li Y, Yin H, et al. Clinical

characteristics and chest CT imaging features of critically ill

COVID-19 patients. Eur Radiol 2020; 30(11): 6151-6160.

https://doi.org/10.1007/s00330-020-06955-x.

Petrie JR, Guzik TJ, Touyz RM. Diabetes, Hypertension, and

Cardiovascular Disease: Clinical insights and vascular

mechanisms. Can J Cardiol 2018; 34(5): 575-584.

https://doi.org/10.1016/j.cjca.2017.12.005.

Yanai H. A significance of high prevalence of diabetes and

hypertension in severe COVID-19 Patients. J Clin Med Res 2020;

(6): 389-392. https://doi.org/ 10.14740/jocmr4218.

Nandy K, Salunke A, Pathak SK, Pandey A, Doctor C, Puj K, et al.

Coronavirus disease (COVID-19): A systematic review and metaanalysis to evaluate the impact of various comorbidities on

serious events. Diabetes Metab Syndr 2020; 14(5): 1017-1025.

https://doi.org/10.1016/j.dsx.2020.06.064.

Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C, et al. Diabetes is

a risk factor for the progression and prognosis of COVID-19.

Diabetes Metab Res Rev 2020; 36(7): e3319.

https://doi.org/10.1002/dmrr.3319.

Muniyappa R, Gubbi S. COVID-19 pandemic, coronaviruses, and

diabetes mellitus. Am J Physiol Endocrinol Metab 2020; 318(5):

E736-E741. https://doi.org/10.1152/ajpendo.00124.2020.

Pal R, Bhansali A. COVID-19, diabetes mellitus and ACE2: The

conundrum. Diabetes Res Clin Pract 2020; 162: 108132.

https://doi.org/10.1016/j.diabres.2020.108132.

Jafar N, Edriss H, Nugent K. The Effect of Short-Term

Hyperglycemia on the Innate Immune System. Am J Med Sci

; 351(2): 201-211.

https://doi.org/10.1016/j.amjms.2015.11.011.

Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor Recognition

by the Novel Coronavirus from Wuhan: an Analysis Based on

Decade-Long Structural Studies of SARS Coronavirus. J Virol

; 94(7): e00127. https://doi.org/10.1128/JVI.00127-20.

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al; China

Novel Coronavirus investigating and research team. A Novel

Coronavirus from Patients with Pneumonia in China, 2019. N

Engl J Med 2020; 382(8): 727-733.

https://doi.org/10.1056/NEJMoa2001017.

Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early

Transmission Dynamics in Wuhan, China, of Novel CoronavirusInfected Pneumonia. N Engl J Med 2020; 382(13): 1199-1207. https://doi.org/10.1056/NEJMoa2001316